清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

医学 普萘洛尔 随机对照试验 婴儿血管瘤 儿科 血管瘤 外科 麻醉
作者
Christine Léauté-Labrèze,Peter H. Hoeger,J. Mazereeuw‐Hautier,Laurent Guibaud,Eulàlia Baselga,Gintas Pošiūnas,R Phillips,Héctor Cáceres,Juan Carlos López‐Gutiérrez,Rosalía Ballona,Sheila Fallon Friedlander,Julie Powell,Danuta Perek,B Metz,S. Barbarot,A. Maruani,Zsuzsanna Zsófia Szalai,Alfons L. Krol,O. Boccara,R. Foelster‐Holst
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:372 (8): 735-746 被引量:871
标识
DOI:10.1056/nejmoa1404710
摘要

BACKGROUND: Oral propranolol has been used to treat complicated infantile hemangiomas, although data from randomized, controlled trials to inform its use are limited. METHODS: We performed a multicenter, randomized, double-blind, adaptive, phase 2-3 trial assessing the efficacy and safety of a pediatric-specific oral propranolol solution in infants 1 to 5 months of age with proliferating infantile hemangioma requiring systemic therapy. Infants were randomly assigned to receive placebo or one of four propranolol regimens (1 or 3 mg of propranolol base per kilogram of body weight per day for 3 or 6 months). A preplanned interim analysis was conducted to identify the regimen to study for the final efficacy analysis. The primary end point was success (complete or nearly complete resolution of the target hemangioma) or failure of trial treatment at week 24, as assessed by independent, centralized, blinded evaluations of standardized photographs. RESULTS: Of 460 infants who underwent randomization, 456 received treatment. On the basis of an interim analysis of the first 188 patients who completed 24 weeks of trial treatment, the regimen of 3 mg of propranolol per kilogram per day for 6 months was selected for the final efficacy analysis. The frequency of successful treatment was higher with this regimen than with placebo (60% vs. 4%, P<0.001). A total of 88% of patients who received the selected propranolol regimen showed improvement by week 5, versus 5% of patients who received placebo. A total of 10% of patients in whom treatment with propranolol was successful required systemic retreatment during follow-up. Known adverse events associated with propranolol (hypoglycemia, hypotension, bradycardia, and bronchospasm) occurred infrequently, with no significant difference in frequency between the placebo group and the groups receiving propranolol. CONCLUSIONS: This trial showed that propranolol was effective at a dose of 3 mg per kilogram per day for 6 months in the treatment of infantile hemangioma. (Funded by Pierre Fabre Dermatologie; ClinicalTrials.gov number, NCT01056341.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
明理的璎完成签到,获得积分10
2秒前
luyun发布了新的文献求助10
11秒前
Magic完成签到 ,获得积分10
17秒前
ghost完成签到 ,获得积分10
19秒前
Dipsy123完成签到,获得积分10
21秒前
n01W97给勤奋不凡的求助进行了留言
23秒前
李健的应助被蜗牛好好飞采纳,获得10
25秒前
26秒前
怕孤独的亚男完成签到,获得积分10
27秒前
29秒前
TingtingGZ发布了新的文献求助10
32秒前
lay完成签到,获得积分10
37秒前
44秒前
53秒前
平淡大船完成签到,获得积分10
58秒前
虚心晓灵完成签到,获得积分10
58秒前
tuimao发布了新的文献求助10
1分钟前
Lucas的应助被tuimao采纳,获得10
1分钟前
等风的拾荒者完成签到 ,获得积分10
1分钟前
1分钟前
AiQi完成签到 ,获得积分10
1分钟前
伶俐的万言完成签到,获得积分10
1分钟前
在水一方的应助被WQY采纳,获得10
1分钟前
TingtingGZ发布了新的文献求助10
1分钟前
1分钟前
WQY发布了新的文献求助10
1分钟前
旧城旧巷等旧人完成签到 ,获得积分10
2分钟前
2分钟前
殷勤的鸵鸟完成签到,获得积分10
2分钟前
loen完成签到,获得积分10
2分钟前
杉寒完成签到,获得积分10
2分钟前
务实的绮琴完成签到,获得积分10
2分钟前
2分钟前
ramsey33完成签到 ,获得积分10
2分钟前
tuimao发布了新的文献求助10
2分钟前
Orange的应助被tuimao采纳,获得20
2分钟前
科研通AI6.2的应助被JJYYY采纳,获得10
3分钟前
tfonda完成签到 ,获得积分10
3分钟前
Tree_QD完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173225
求助须知:如何正确求助?哪些是违规求助? 9565567
关于积分的说明 21780511
捐赠科研通 7767377
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555750
邀请新用户注册赠送积分活动 2476697